验证数据展示
经过测试的应用
| Positive IF-P detected in | mouse testis tissue |
For other applications, we recommend the unconjugated version of this antibody, 66601-1-Ig
推荐稀释比
| 应用 | 推荐稀释比 |
|---|---|
| Immunofluorescence (IF)-P | IF-P : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
产品信息
CL594-66601 targets PALLD,palladin in IF-P applications and shows reactivity with Human, rat, pig samples.
| 经测试应用 | IF-P Application Description |
| 经测试反应性 | Human, rat, pig |
| 免疫原 |
CatNo: Ag1288 Product name: Recombinant human PALLD,palladin protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 127-510 aa of BC013867 Sequence: APFFEMKLKHYKIFEGMPVTFTCRVAGNPKPKIYWFKDGKQISPKSDHYTIQRDLDGTCSLHTTASTLDDDGNYTIMAANPQGRISCTGRLMVQAVNQRGRSPRSPSGHPHVRRPRSRSRDSGDENEPIQERFFRPHFLQAPGDLTVQEGKLCRMDCKVSGLPTPDLSWQLDGKPVRPDSAHKMLVRENGVHSLIIEPVTSRDAGIYTCIATNRAGQNSFSLELVVAAKEAHKPPVFIEKLQNTGVADGYPVRLECRVLGVPPPQIFWKKENESLTHSTDRVSMHQDNHGYICLLIQGATKEDAGWYTVSAKNEAGIVSCTARLDVYTQWHQQSQSTKPKKVRPSASRYAALSDQGLDIKAAFQPEANPSHLTLNTALVESEDL 种属同源性预测 |
| 宿主/亚型 | Mouse / IgG2a |
| 抗体类别 | Monoclonal |
| 产品类型 | Antibody |
| 全称 | palladin, cytoskeletal associated protein |
| 别名 | CGI 151, FLJ22190, FLJ38193, FLJ39139, KIAA0992, palladin, PALLD, PALLD,palladin, PNCA1, Sarcoma antigen NY SAR 77, SIH002 |
| 计算分子量 | 1383 aa, 151 kDa |
| 观测分子量 | 151 kDa |
| GenBank蛋白编号 | BC013867 |
| 基因名称 | palladin |
| Gene ID (NCBI) | 23022 |
| RRID | AB_3673506 |
| 偶联类型 | CoraLite®594 Fluorescent Dye |
| 最大激发/发射波长 | 588 nm / 604 nm |
| 形式 | Liquid |
| 纯化方式 | Protein A purification |
| UNIPROT ID | Q8WX93 |
| 储存缓冲液 | PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3. |
| 储存条件 | Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
实验方案
| Product Specific Protocols | |
|---|---|
| IF protocol for CL594 PALLD,palladin antibody CL594-66601 | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
